Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Return on Sales (2017 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Return on Sales for 17 consecutive years, with 0.0% as the latest value for Q4 2025.

  • Quarterly Return on Sales fell 5.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.32% through Dec 2025, down 31.0% year-over-year, with the annual reading at 0.32% for FY2025, 31.0% down from the prior year.
  • Return on Sales hit 0.0% in Q4 2025 for Integra Lifesciences Holdings, up from 0.01% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.13% in Q4 2022 to a low of 1.16% in Q2 2025.
  • Historically, Return on Sales has averaged 0.01% across 5 years, with a median of 0.05% in 2023.
  • Biggest five-year swings in Return on Sales: increased 10bps in 2021 and later plummeted -114bps in 2025.
  • Year by year, Return on Sales stood at 0.11% in 2021, then grew by 19bps to 0.13% in 2022, then crashed by -62bps to 0.05% in 2023, then dropped by -12bps to 0.04% in 2024, then crashed by -109bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for IART at 0.0% in Q4 2025, 0.01% in Q3 2025, and 1.16% in Q2 2025.